Search Results - "Ackl, N."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    A novel mutation in CACNA1A associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline by Freilinger, T, Ackl, N, Ebert, A, Schmidt, C, Rautenstrauss, B, Dichgans, M, Danek, A

    Published in Journal of the neurological sciences (15-01-2011)
    “…Abstract Hemiplegic migraine (HM) is a rare and severe subtype of migraine with aura, characterized by some degree of hemiparesis and other aura symptoms…”
    Get full text
    Journal Article
  2. 2

    A Pair of Siblings with a rare R5H-Mutation in Exon 1 of the MAPT-Gene by Henz, S, Ackl, N, Knels, C, Rominger, A, Flatz, W, Teipel, S, Huppertz, H J, Roeber, S, Neumann, M, Danek, A

    Published in Fortschritte der Neurologie-Psychiatrie (01-07-2015)
    “…We report on a female patient presenting with primary progressive aphasia (PPA) and her brother presenting with psychosis. Both siblings had an R5H-mutation in…”
    Get more information
    Journal Article
  3. 3

    Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated by Zobel, Astrid W, Nickel, Thomas, Künzel, Heike E, Ackl, Nibal, Sonntag, Annette, Ising, Marcus, Holsboer, Florian

    Published in Journal of psychiatric research (01-05-2000)
    “…Clinical and preclinical data suggest that unrestrained secretion of corticoctropin-releasing hormone (CRH) in the CNS produces several signs and symptoms of…”
    Get full text
    Journal Article
  4. 4

    Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease by Ackl, Nibal, Ising, Marcus, Schreiber, Yvonne A., Atiya, Monika, Sonntag, Annette, Auer, Dorothee P.

    Published in Neuroscience letters (12-08-2005)
    “…Mild cognitive impairment (MCI) defines a group of otherwise healthy elderly subjects with a markedly elevated risk of developing Alzheimer's disease (AD). In…”
    Get full text
    Journal Article
  5. 5

    Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects by Künzel, Heike E, Zobel, Astrid W, Nickel, Thomas, Ackl, Nibal, Uhr, Manfred, Sonntag, Annette, Ising, Marcus, Holsboer, Florian

    Published in Journal of psychiatric research (01-11-2003)
    “…A dysregulation of the hypothalamus-pituitary-adrenocortical (HPA) system has been hypothesized to account for a myriad of cardinal symptoms of affective…”
    Get full text
    Journal Article
  6. 6

    Clinical and neurobiological effects of tianeptine and paroxetine in major depression by NICKEL, Thomas, SONNTAG, Annette, ZIHL, Josef, HOLSBOER, Florian, SCHILL, Julia, ZOBEL, Astrid W, ACKL, Nibal, BRUNNAUER, Alexander, MURCK, Harald, ISING, Marcus, YASSOURIDIS, Alexander, STEIGER, Axel

    Published in Journal of clinical psychopharmacology (01-04-2003)
    “…Selective serotonin reuptake inhibitors (SSRIs) are widely used as effective pharmacological agents to treat depressive disorders. In contrast to the SSRIs,…”
    Get full text
    Journal Article
  7. 7

    Amyloid positron-emission-tomography with [ 18  F-florbetaben in the diagnostic workup of dementia patients by Schönecker, S, Prix, C, Raiser, T, Ackl, N, Wlasich, E, Stenglein-Krapf, G, Mille, E, Brendel, M, Sabri, O, Patt, M, Barthel, H, Bartenstein, P, Levin, J, Rominger, A, Danek, A

    Published in Nervenarzt (01-02-2017)
    “…To this day the definite diagnosis of Alzheimer's disease still relies on post-mortem histopathological detection of neurofibrillary tangles and beta-amyloid…”
    Get full text
    Journal Article
  8. 8

    Amyloid-Positronenemissionstomographie mit [18 F]-Florbetaben in der Demenzdiagnostik by Schönecker, S., Prix, C., Raiser, T., Ackl, N., Wlasich, E., Stenglein-Krapf, G., Mille, E., Brendel, M., Sabri, O., Patt, M., Barthel, H., Bartenstein, P., Levin, J., Rominger, A., Danek, A.

    Published in Nervenarzt (01-02-2017)
    “…Zusammenfassung Hintergrund Eine gesicherte Diagnose der Alzheimer-Krankheit beruht auf dem histologischen Nachweis von Neurofibrillen und…”
    Get full text
    Journal Article
  9. 9

    Toward a Reliable Distinction Between Patients with Mild Cognitive Impairment and Alzheimer-Type Dementia Versus Major Depression by Post, Anke, Ackl, Nibal, Rücker, Monika, Schreiber, Yvonne, Binder, Elisabeth B., Ising, Marcus, Sonntag, Annette, Holsboer, Florian, Almeida, Osborne F.X.

    Published in Biological psychiatry (1969) (01-05-2006)
    “…Cerebrospinal fluid (CSF) levels of soluble amyloid precursor protein (sAPP) and its α-secreted form (α-sAPP) were investigated as a means to distinguish…”
    Get full text
    Journal Article
  10. 10

    Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression by Künzel, Heike E., Ising, Marcus, Zobel, Astrid W., Nickel, Thomas, Ackl, Nibal, Sonntag, Annette, Holsboer, Florian, Uhr, Manfred

    Published in Journal of psychiatric research (01-03-2005)
    “…Weight gain during treatment with psychotropic drugs is frequently observed and is assumed to be responsible for non-compliance and for an elevated risk to…”
    Get full text
    Journal Article
  11. 11

    Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia by Boban, Marina, Grbić, Kristina, Mladinov, Mihovil, Hof, Patrick R, Süssmair, Christine, Ackl, Nibal, Stanić, Gabrijela, Bader, Benedikt, Danek, Adrian, Simić, Goran

    Published in Collegium antropologicum (01-01-2008)
    “…Alzheimer's disease (AD) and vascular dementia (VaD) are the two most common causes of dementia in old people. They remain difficult to differentiate in…”
    Get more information
    Journal Article
  12. 12